Pulse Biosciences
CompanyUnited States
Pulse Biosciences develops one asset, in phase 2 (nPulse Cardiac Catheter System in atrial fibrillation). Mostly device; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 2
- 0
- Trials
- 0
- Signals
Pipeline
1nPulse Cardiac Catheter System
Nanosecond pulsed field ablation technology for cardiac tissue ablation
Phase 2, Device, atrial fibrillation
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies6